Launch Planning and Implementation Support for Novel Biologic

Due Diligence

ADVI helped management design and execute a series of interlocking P&R and market access imperatives.

ADVI helped management design and execute a series of interlocking P&R and market access imperatives that include global pricing policy, Core Value Dossier (CVD), transition from special license sales programs to full market access, ongoing support of internal P&R needs of senior management and affiliates, pricing database to monitor developments in other high-profile launches, decision support tool to prioritize the optimal P&R and launch sequence strategy, P&R implications of follow-on indications.

CEO insights

Real analysis from people who’ve been there

Due Diligence

Commercial Contracting Process, Evaluations, and Metrics

ADVI helped a client understand the different ways of looking at account performance, plus embed contracting metrics into the contracting process.

21 Apr 2016

Due Diligence

Payer/KOL P&R Input to New Oncology Biologic Development Plan

ADVI conducted primary research with payer informant KOLs and secondary research to augment company knowledge and develop the “right questions” and TPPs.

21 Apr 2016

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.